Drug Type Hematopoietic stem cell therapy |
Synonyms- |
Target |
Mechanism CD19 modulators(B-lymphocyte antigen CD19 modulators), STING agonists(Stimulator of interferon genes agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Solid tumor | Preclinical | DK | 31 Oct 2023 |